共 50 条
- [1] PRECLINICAL DEVELOPMENT OF THE PI3K ALPHA SELECTIVE AND PIK3CA MUTANT SELECTIVE INHIBITOR GDC-0077 AND PREDICTION OF ITS HUMAN PHARMACOKINETICS[J]. DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S37 - S37Pang, JodieBaumgardner, MatthewBraun, Marie-GabrielleCheong, JonathanEdgar, KyleFriedman, LoriHanan, EmilyJaochico, AllanMa, ShuguangPlise, EmileSchmidt, StephenLiu, NingSong, KyungStaben, SteveSalphati, Laurent
- [2] Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (24) : 16589 - 16621Hanan, Emily J.Braun, Marie-GabrielleHeald, Robert A.MacLeod, CalumChan, ConnieClausen, SaundraEdgar, Kyle A.Eigenbrot, CharlesElliott, RichardEndres, NicholasFriedman, Lori S.Gogol, EmilyGu, Xiao-HuiThibodeau, Rebecca HongJackson, Philip S.Kiefer, James R.Knight, Jamie D.Nannini, MichelleNarukulla, RamanPace, AmandaPang, JodiePurkey, Hans E.Salphati, LaurentSampath, DeepakSchmidt, StephenSideris, SteveSong, KyungSujatha-Bhaskar, SwathiUltsch, MarkWallweber, HeidiXin, JianfengYeap, SiewKuenYoung, AmyZhong, YuStaben, Steven T.
- [3] Synthesis of PI3K inhibitor GDC-0077 via a stereocontrolled N-arylation of α-amino acids[J]. TETRAHEDRON, 2019, 75 (32) : 4351 - 4357Han, ChongKelly, Sean M.Cravillion, TheresaSavage, Scott J.Nguyen, TinaGosselin, Francis
- [5] GDC-0077 is a selective PI3K alpha inhibitor with robust efficacy in PIK3CA mutant hormone-positive breast cancer models[J]. CANCER RESEARCH, 2020, 80 (04)Edgar, KyleHong, RebeccaSong, KyungSchmidt, StevenHafner, MarcArrazate, AlfonsoWilliams, ErinDe La Cruz, CecileOeh, JasonSampath, DeepakStaben, SteveFriedman, Lori
- [6] Discovery of GDC-0077: A highly selective inhibitor of PI3K-alpha that induces degradation of mutant-p110 alpha protein[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256Braun, Marie-Gabrielle
- [7] RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy[J]. CANCER DISCOVERY, 2022, 12 (01) : 204 - 219Song, Kyung W.Edgar, Kyle A.Hanan, Emily J.Hafner, MarcOeh, JasonMerchant, MarkSampath, DeepakNannini, Michelle A.Hong, RebeccaPhu, LilianForrest, William F.Stawiski, EricSchmidt, StephenEndres, NicholasGuan, JaneWallin, Jeffrey J.Cheong, JonathanPlise, Emile G.Phillips, Gail D. LewisSalphati, LaurentHeffron, Timothy P.Olivero, Alan G.Malek, ShivaStaben, Steven T.Kirkpatrick, Donald S.Dey, AnweshaFriedman, Lori S.
- [8] Discovery of GDC-0077: A highly selective inhibitor of PI3K-alpha that induces degradation of mutant-p110 alpha protein[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254Braun, Marie-GabrielleChan, ConnieClausen, SaundraEdgar, KyleEigenbrot, CharlesEliott, RichardEndres, NickFriedman, LoriGerland, KeiraGu, Xiao-HuHamilton, PatHan, ChongHanan, EmilyHong, RebeccaJackson, PhilipKelly, SeanKnight, JamieLee, Man-LingLu, AijunMacLeod, CalumMcKenzie, AijaNannini, MichelleNarukulla, RamanNguyen, AmandaPang, JodiePurkey, HansSalphati, LaurentSampath, DeepakSchmidt, StephenSchutt, LeahHeald, RobertSong, KyungUltsch, MarkXin, JianfengYeap, KuenYoung, AmyZhong, ZoeStaben, Steven
- [9] Process development of PI3K inhibitor GDC-0980[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248Humphries, Theresa
- [10] GDC-0941 PI3K inhibitor activity in preclinical lung cancer models[J]. EJC SUPPLEMENTS, 2010, 8 (07): : 51 - 51Friedman, L.Belvin, M.Berry, L.Haverty, P.Hoeflich, K.Lackner, M.Sampath, D.Wallin, J.Yauch, B.